Background: Clinical trials with non-profit promoters are frequently performed in oncology and represent a highly valuable source of information.
Methods: To describe the costs of insurance policies and their determinants, data were collected from 12 Italian non-profit promoters of cancer trials. The cost of policies was expressed as per-patient premium.